Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Liver Diseases

  Free Subscription


18.02.2019

3 Biochem Biophys Res Commun
1 BMC Cancer
1 BMC Gastroenterol
2 Cancer Res
1 Dig Dis Sci
1 Endoscopy
4 Eur Radiol
3 Gastroenterology
7 Hepatology
1 Indian J Gastroenterol
1 J Gastroenterol
3 J Hepatol
1 J Pediatr
1 Lancet Gastroenterol Hepatol
1 Oncogene
8 PLoS One
1 Transplant Proc
3 Transplantation


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Biochem Biophys Res Commun

  1. GONG W, Liu Y, Qu H, Liu A, et al
    The effect of CTCF binding sites destruction by CRISPR/Cas9 on transcription of metallothionein gene family in liver hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2019 Feb 6. pii: S0006-291X(19)30136.
    PubMed     Text format     Abstract available

  2. HUO X, Li H, Li Z, Yan C, et al
    Transcriptomic analyses of oncogenic hepatocytes reveal common and different molecular pathways of hepatocarcinogenesis in different developmental stages and genders in kras(G12V) transgenic zebrafish.
    Biochem Biophys Res Commun. 2019 Feb 7. pii: S0006-291X(19)30189.
    PubMed     Text format     Abstract available

  3. TAO X, Hu Y, Li L, Xu R, et al
    Genetic deletion of beta2 adrenergic receptors exacerbates hepatocellular lipid accumulation in high-fat diet mice.
    Biochem Biophys Res Commun. 2019 Feb 12. pii: S0006-291X(19)30224.
    PubMed     Text format     Abstract available


    BMC Cancer

  4. NAGATA N, Nishijima T, Niikura R, Yokoyama T, et al
    Increased risk of non-AIDS-defining cancers in Asian HIV-infected patients: a long-term cohort study.
    BMC Cancer. 2018;18:1066.
    PubMed     Text format     Abstract available


    BMC Gastroenterol

  5. ESTEP M, Mehta R, Bratthauer G, Alaparthi L, et al
    Hepatic sonic hedgehog protein expression measured by computer assisted morphometry significantly correlates with features of non-alcoholic steatohepatitis.
    BMC Gastroenterol. 2019;19:27.
    PubMed     Text format     Abstract available


    Cancer Res

  6. KWEE SA, Tiirikainen M, Sato MM, Acoba JD, et al
    Transcriptomics associates molecular features with 18F-fluorocholine PET/CT imaging phenotype and its potential relationship to survival in hepatocellular carcinoma.
    Cancer Res. 2019 Feb 13. pii: 0008-5472.CAN-18-3837.
    PubMed     Text format     Abstract available

  7. HAN J, Meng J, Wang X, Yin S, et al
    YY1 complex promotes Quaking expression via super-enhancer binding during EMT of hepatocellular carcinoma.
    Cancer Res. 2019 Feb 13. pii: 0008-5472.CAN-18-2238.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  8. ARDOLINO E, Wang SS, Patwardhan VR
    Evidence of Significant Ceftriaxone and Quinolone Resistance in Cirrhotics with Spontaneous Bacterial Peritonitis.
    Dig Dis Sci. 2019 Feb 14. pii: 10.1007/s10620-019-05519.
    PubMed     Text format     Abstract available


    Endoscopy

  9. INOUE T, Ibusuki M, Kitano R, Kobayashi Y, et al
    Balloon enteroscopy-assisted radial incision and cutting method for refractory hepaticojejunostomy anastomotic strictures.
    Endoscopy. 2019 Feb 13. doi: 10.1055/a-0838-5557.
    PubMed     Text format     Abstract available


    Eur Radiol

  10. CARLING U, Barkhatov L, Reims HM, Storas T, et al
    Can we ablate liver lesions close to large portal and hepatic veins with MR-guided HIFU? An experimental study in a porcine model.
    Eur Radiol. 2019 Feb 8. pii: 10.1007/s00330-018-5996.
    PubMed     Text format     Abstract available

  11. LEE DH, Lee JM, Kim PN, Jang YJ, et al
    Whole tumor ablation of locally recurred hepatocellular carcinoma including retained iodized oil after transarterial chemoembolization improves progression-free survival.
    Eur Radiol. 2019 Feb 15. pii: 10.1007/s00330-018-5993.
    PubMed     Text format     Abstract available

  12. MA X, Wei J, Gu D, Zhu Y, et al
    Preoperative radiomics nomogram for microvascular invasion prediction in hepatocellular carcinoma using contrast-enhanced CT.
    Eur Radiol. 2019 Feb 15. pii: 10.1007/s00330-018-5985.
    PubMed     Text format     Abstract available

  13. TRUHN D, Kuhl CK, Ciritsis A, Barabasch A, et al
    A New Model for MR Evaluation of Liver Function with Gadoxetic Acid, Including Both Uptake and Excretion.
    Eur Radiol. 2019;29:383-391.
    PubMed     Text format     Abstract available


    Gastroenterology

  14. INTAGLIATA NM, Caldwell SH, Tripodi A
    Diagnosis, Development, and Treatment of Portal Vein Thrombosis in Patients With and Without Cirrhosis.
    Gastroenterology. 2019 Feb 13. pii: S0016-5085(19)30372.
    PubMed     Text format     Abstract available

  15. THABUT D, Bureau C, Layese R, Bourcier V, et al
    Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients with Compensated Cirrhosis and a Sustained Response to Antiviral Therapy.
    Gastroenterology. 2019 Feb 12. pii: S0016-5085(18)35303.
    PubMed     Text format     Abstract available

  16. TEUFEL M, Seidel H, Kochert K, Meinhardt G, et al
    Biomarkers associated with response to regorafenib in patients with hepatocellular carcinoma.
    Gastroenterology. 2019 Feb 6. pii: S0016-5085(19)30361.
    PubMed     Text format     Abstract available


    Hepatology

  17. ALBILLOS A, Munoz L, Alvarez-Mon M
    Reply to: Carbon Tetrachloride (CCl4)-Induced Classical Liver Cirrhosis Model: Revisiting The Mode Of Action.
    Hepatology. 2019 Feb 8. doi: 10.1002/hep.30554.
    PubMed     Text format     Abstract available

  18. DEY P
    Carbon Tetrachloride (CCl4 )-Induced Classical Liver Cirrhosis Model: Revisiting The Mode Of Action.
    Hepatology. 2019 Feb 8. doi: 10.1002/hep.30555.
    PubMed     Text format     Abstract available

  19. QIAO Y, Wang J, Karagoz E, Liang B, et al
    Axin1 deletion induced hepatocarcinogenesis requires intact beta-Catenin but not Notch cascade in mice.
    Hepatology. 2019 Feb 8. doi: 10.1002/hep.30556.
    PubMed     Text format     Abstract available

  20. TONG J, Han CJ, Zhang JZ, He WZ, et al
    Hepatic IRF6 alleviates liver steatosis and metabolic disorder by transcriptionally suppressing PPARgamma.
    Hepatology. 2019 Feb 12. doi: 10.1002/hep.30559.
    PubMed     Text format     Abstract available

  21. LAI SW, Lin CL
    Hip fracture risk in patients with cirrhosis: does diabetes mellitus matter?
    Hepatology. 2019 Feb 14. doi: 10.1002/hep.30566.
    PubMed     Text format     Abstract available

  22. NGUYEN MH
    Hip fracture risk in patients with cirrhosis: does diabetes mellitus matter?
    Hepatology. 2019 Feb 14. doi: 10.1002/hep.30560.
    PubMed     Text format     Abstract available

  23. WEN W, Schwabe RF
    Soluble fibers improve metabolic syndrome but may cause liver disease and hepatocellular carcinoma.
    Hepatology. 2019 Feb 14. doi: 10.1002/hep.30565.
    PubMed     Text format     Abstract available


    Indian J Gastroenterol

  24. PHILIPS CA, Augustine P, Ahamed R, Padsalgi G, et al
    Intermittent or continuous infusion of terlipressin for acute variceal bleeding-"cherry picking" to make it simpler.
    Indian J Gastroenterol. 2018;37:563-564.
    PubMed     Text format    


    J Gastroenterol

  25. KIM SK, Takeda H, Takai A, Matsumoto T, et al
    Comprehensive analysis of genetic aberrations linked to tumorigenesis in regenerative nodules of liver cirrhosis.
    J Gastroenterol. 2019 Feb 12. pii: 10.1007/s00535-019-01555.
    PubMed     Text format     Abstract available


    J Hepatol

  26. HOUGHTON D, Zalewski P, Hallsworth K, Cassidy S, et al
    The degree of hepatic steatosis associates with impaired cardiac and autonomic function.
    J Hepatol. 2019 Feb 12. pii: S0168-8278(19)30112.
    PubMed     Text format     Abstract available

  27. TAPPER EB, Romero-Gomez M, Bajaj JS
    Hepatic encephalopathy and traffic accidents: Vigilance is needed!
    J Hepatol. 2019 Feb 11. pii: S0168-8278(19)30031.
    PubMed     Text format    


  28. Corrigendum to "EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma" [J Hepatol 69 (2018) 182-236].
    J Hepatol. 2019 Feb 7. pii: S0168-8278(19)30034.
    PubMed     Text format    


    J Pediatr

  29. LURZ E, Quammie C, Englesbe M, Alonso EM, et al
    Frailty in Children with Liver Disease: A Prospective Multicenter Study.
    J Pediatr. 2018;194:109-115.
    PubMed     Text format     Abstract available


    Lancet Gastroenterol Hepatol


  30. Correction to Lancet Gastroenterol Hepatol 2019; 4: 186-87.
    Lancet Gastroenterol Hepatol. 2019;4:e2.
    PubMed     Text format    


    Oncogene

  31. TORRES-HERNANDEZ A, Wang W, Nikiforov Y, Tejada K, et al
    Targeting SYK signaling in myeloid cells protects against liver fibrosis and hepatocarcinogenesis.
    Oncogene. 2019 Feb 11. pii: 10.1038/s41388-019-0734.
    PubMed     Text format     Abstract available


    PLoS One

  32. MEHTA AS, Lau DT, Wang M, Islam A, et al
    Application of the Doylestown algorithm for the early detection of hepatocellular carcinoma.
    PLoS One. 2018;13:e0203149.
    PubMed     Text format     Abstract available

  33. FABRELLAS N, Hernandez R, Graupera I, Sola E, et al
    Prevalence of hepatic steatosis as assessed by controlled attenuation parameter (CAP) in subjects with metabolic risk factors in primary care. A population-based study.
    PLoS One. 2018;13:e0200656.
    PubMed     Text format     Abstract available

  34. CHOI YJ, Lee DH, Han KD, Yoon H, et al
    Is nonalcoholic fatty liver disease associated with the development of prostate cancer? A nationwide study with 10,516,985 Korean men.
    PLoS One. 2018;13:e0201308.
    PubMed     Text format     Abstract available

  35. MORI S, Arima N, Ito M, Fujiyama S, et al
    Non-alcoholic steatohepatitis-like pattern in liver biopsy of rheumatoid arthritis patients with persistent transaminitis during low-dose methotrexate treatment.
    PLoS One. 2018;13:e0203084.
    PubMed     Text format     Abstract available

  36. ABDELHAFEZ OH, Fawzy MA, Fahim JR, Desoukey SY, et al
    Hepatoprotective potential of Malvaviscus arboreus against carbon tetrachloride-induced liver injury in rats.
    PLoS One. 2018;13:e0202362.
    PubMed     Text format     Abstract available

  37. KANG SJ, Kim HJ, Kim D, Ahmed A, et al
    Association between cagA negative Helicobacter pylori status and nonalcoholic fatty liver disease among adults in the United States.
    PLoS One. 2018;13:e0202325.
    PubMed     Text format     Abstract available

  38. PEISELER M, Reiners D, Pinnschmidt HO, Sebode M, et al
    Risk of endoscopic biliary interventions in primary sclerosing cholangitis is similar between patients with and without cirrhosis.
    PLoS One. 2018;13:e0202686.
    PubMed     Text format     Abstract available

  39. KRUK B, Liebe R, Milkiewicz M, Wunsch E, et al
    PNPLA3 p.I148M and TM6SF2 p.E167K variants do not predispose to liver injury in cholestatic liver diseases: A prospective analysis of 178 patients with PSC.
    PLoS One. 2018;13:e0202942.
    PubMed     Text format     Abstract available


    Transplant Proc

  40. MAGGI U, Iavarone M, Fabbi M, Yiu D, et al
    Liver Transplantations and Brain Dead Donors With Alcohol Abuse.
    Transplant Proc. 2018;50:3105-3110.
    PubMed     Text format     Abstract available


    Transplantation

  41. CHEN K, Sheng J, Ma B, Cao W, et al
    Suppression of hepatocellular carcinoma by mycophenolic acid in experimental models and in patients.
    Transplantation. 2019 Feb 4. doi: 10.1097/TP.0000000000002647.
    PubMed     Text format     Abstract available

  42. KOC C, Akbulut S, Ozdemir F, Kose A, et al
    Analysis of Risk Factors Affecting the Development of Infection in Artificial Vascular Grafts Used for Reconstruction of Middle Hepatic Vein Tributaries in Living Donor Liver Transplantation.
    Transplantation. 2019 Feb 4. doi: 10.1097/TP.0000000000002583.
    PubMed     Text format     Abstract available

  43. RHU J, Kim JM, Choi GS, Hyuck C, et al
    The impact of extra-anatomical hepatic artery reconstruction during living donor liver transplantation on biliary complications and graft and patient survival.
    Transplantation. 2019 Feb 4. doi: 10.1097/TP.0000000000002601.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: